Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegilidine vs sufentanil for patient-controlled intravenous analgesia after total knee arthroplasty
ChiCTR2600122108Phase 4Not yet recruiting
- Sponsor
- The First People's Hospital of Jingzhou
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegileridine in postoperative pain (2 arms), sponsored by The First People's Hospital of Jingzhou. Primary endpoint: QoR-15 score at 24 hours after surgery. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
tegileridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600122108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122108.